IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Opaleye Management Inc.

Q4 2025 Holdings

Filed 2026-02-17 | 54 holdings | $757.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2026-04-13) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$35.3M330,0004.7%
Eton Pharmaceuticals Inc(ETON)COM29772L108$48.4M2,860,0006.4%
Liquidia Corporation(LQDA)COM NEW53635D202$85.0M2,435,00011.2%
Harrow Health Inc(HROW)COM415858109$191.3M3,905,00025.2%
PreviousPage 2 of 2